- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
902
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
902 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
301260 | CN¥13.83 | -0.9% | 23.9% | CN¥6.7b | n/a | PS1.3x | E68.7% | 0% | Consumer Durables | ||
DATA | UK£1.78 | -1.9% | -10.8% | UK£1.4b | UK£2.66 | PE42.6x | E25.8% | 2.6% | Commercial Services | ||
ABDL | ₹394.40 | -2.7% | n/a | ₹110.3b | ₹466.67 | PE96.9x | E35.6% | n/a | Food, Beverage & Tobacco | ||
BUFAB | SEK 464.20 | 2.0% | 24.7% | SEK 17.4b | SEK 467.50 | PE34.4x | E20.8% | 1.1% | Capital Goods | ||
300820 | CN¥50.58 | -2.4% | 42.6% | CN¥11.1b | CN¥58.00 | PE24.5x | E26.3% | 0.8% | Capital Goods | ||
S32 | AU$3.36 | -5.1% | 0.6% | AU$15.1b | AU$3.81 | PS1.7x | E52.0% | 1.7% | Materials | ||
CDR | CA$1.83 | 1.7% | 4.0% | CA$118.7m | CA$4.85 | PS3.3x | E145.8% | n/a | Energy | ||
688046 | CN¥13.06 | -3.2% | 10.6% | CN¥5.3b | CN¥14.00 | PE38.3x | E24.2% | 0.5% | Pharmaceuticals & Biotech | ||
NISB | NOK 100.02 | -3.8% | -8.2% | NOK 112.9m | NOK 104.00 | PB0.2x | E29.8% | 5.7% | Banks | ||
7373 | JP¥1,822.00 | 3.5% | -9.9% | JP¥27.9b | JP¥4,700.00 | PE18.6x | E23.1% | 1.6% | Commercial Services | ||
1818 | HK$12.14 | -1.0% | 65.2% | HK$41.3b | HK$16.58 | PE32x | E38.6% | 0.4% | Materials | ||
TOU | CA$67.31 | -2.4% | 16.3% | CA$25.2b | CA$79.20 | PE16.2x | E28.1% | 5.8% | Energy | ||
A248070 | ₩18,900.00 | -0.3% | -30.4% | ₩912.2b | ₩31,625.00 | PE20.5x | E50.0% | n/a | Tech | ||
IEL | AU$13.34 | 3.7% | -30.9% | AU$3.7b | AU$18.17 | PE28x | E13.8% | 2.5% | Consumer Services | ||
PRVA | US$22.54 | -1.7% | 9.8% | US$2.7b | US$26.00 | PE210.9x | E34.2% | n/a | Healthcare | ||
IDX | AU$3.12 | 6.1% | 58.4% | AU$1.1b | AU$3.40 | PS2.5x | E54.6% | 1.9% | Healthcare | ||
1813 | JP¥2,199.00 | 2.1% | -3.5% | JP¥33.1b | JP¥3,100.00 | PE25.4x | E35.1% | 2.7% | Capital Goods | ||
300702 | CN¥17.32 | 0.4% | 9.8% | CN¥6.0b | CN¥22.42 | PE136.4x | E71.4% | 0.3% | Pharmaceuticals & Biotech | ||
DUKE | UK£0.29 | -4.3% | -10.1% | UK£145.6m | UK£0.46 | PE14.3x | E29.7% | 9.7% | Diversified Financials | ||
3912 | JP¥1,037.00 | 7.8% | 34.3% | JP¥7.5b | n/a | PE252.3x | E40.1% | 3.6% | Media | ||
OTB | UK£2.51 | -1.2% | 70.3% | UK£416.7m | UK£2.86 | PE20x | E20.7% | 1.2% | Consumer Services | ||
1164 | HK$1.53 | -18.2% | -21.9% | HK$11.6b | HK$2.10 | PE27x | E39.2% | 0.4% | Energy | ||
2172 | HK$10.24 | 20.5% | 15.2% | HK$5.9b | HK$12.22 | PE24.4x | E20.4% | 1.5% | Healthcare | ||
7033 | JP¥1,722.00 | 0.5% | -40.9% | JP¥28.6b | JP¥1,980.00 | PE16.5x | E20.1% | 1.7% | Commercial Services |